series-a
Stage
1
Investors
About
Maxion Therapeutics develops first-in-class and best-in-class protein therapeutics using proprietary KnotBody® technology to target ion channel and GPCR-driven diseases including chronic pain, autoimmunity, and cardiovascular disease.
Explore Maxion Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.